References
- Spranger J. International classification of osteochondrodysplasias. The International Working Group on Constitutional Diseases of Bone. Eur J Pediatr 1992; 151: 407–15
- Spranger J, Winterpacht A, Zabel B. The type II collagenopathies: a spectrum of chondrodysplasias. Eur J Pediatr 1994; 153: 56–65
- Kivlrikko K I. Collagens and their abnormalities in a wide spectrum of diseases. Ann Med 1993; 25: 113–26
- Givol D, Yayon A. Complexity of FGF receptors: genetic basis for structural diversity and functional specificity. Faseb J 1992; 6: 3362–9
- Partanen J, Vainikka S, Korhonen J, et al. Diverse receptors for fibroblast growth factors. Prog Growth Factor Res 1992; 4: 69–83
- LeMerrer M, Rousseau F, Legeai-Mallet L, et al. A gene for achondroplasia-hypochondroplasia maps to chromosome 4p. Nat Genet 1994; 6: 318–21
- Velinov M, Siaugenhaupt S A, Stoilov I, et al. The gene for achondroplasia maps to the telomeric region of chromosome 4p. Nat Genet 1994; 6: 314–7
- Francomano C A, Ortiz de Luna R I, Hefferon T W, Hayman M J. Localization of the achondroplasia gene to the distal 2.5 Mb of human chromosome 4p. Hum Mol Genet 1994; 3: 787–92
- The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993; 72: 971–83
- Keegan K, Johnson D E, Williams L T, Hayman M V. Isolation of an additional member of the fibroblast growth factor receptor family, FGFR-3. Proc Natl Acad Sci USA 1991; 88: 1095–9
- Thompson L M, Plummer S, Schalling M, et al. A gene encoding a fibroblast growth factor receptor isolated from the Huntington disease gene region of human chromosome 4. Genomics 1991; 11: 1133–42
- Shiang R, Thompson L M, Zhu Y Z, et al. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell 1994; 78: 335–42
- Rousseau F, Bonaventure J, Legeal-Mallet L, et al. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature 1994; 371: 252–4
- Reardon W, Winter R M, Rutland P, et al. Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome. Nat Genet 1994; 8: 98–103
- Jabs E W, Li X, Scott A F, et al. Jackson–Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2. Nat Genet 1994; 8: 275–9
- Wilkie A OM, Slaney S F, Oldridge M, et al. Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nat Genet 1995; 9: 165–72
- Lajeunie E, Ma H W, Bonaventure J, et al. FGFR2 mutations in Pfeiffer syndrome. Nat Genet 1995; 9: 108
- Rutland P, Pulleyn L J, Reardon W, et al. Identical mutations in the FGFR2 gene cause both Pfeiffer and Crouzon syndrome phenotypes. Nat Genet 1995; 9: 173–6
- Muenke M, Schell U, Hehr A, et al. A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome. Nat Genet 1994; 8: 269–74
- Hästbacka J, Kaitila I, Sistonen P, de la Chapelle A. Diastrophic dysplasia gene maps to the distal long arm of chromosome 5. Proc Natl Acad Sci USA 1990; 87: 8056–9
- Hästbacka J, de la Chapelle A, Mahtani M M, et al. The diastrophic dysplasia gene encodes a novel sulfate transporter: positional cloning by fine-structure linkage disequilibirum mapping. Cell 1994; 78: 1073–87
- Yayon A, Kiagsbrun M, Esko J D, et al. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 1991; 64: 841–8
- Ornitz D M, Yayon A, Flanagan J G, et al. Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells. Mol Cell Biol 1992; 12: 240–7
- Eriebacher A, Filvaroff E H, Gitelman S E, Derynck R. Towards a molecular understanding of skeletal development. Cell 1995; 80: 371–8